Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study of SL-325 in Crohn's Disease Patients

ClinicalTrials.gov ID: NCT07753850

Public ClinicalTrials.gov record NCT07753850. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 4:01 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SL-325 in Participants With Moderately to Severely Active Crohn's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to evaluate the efficacy of SL-325 in adult participants with moderate to severely active Crohn's disease. The study consists of a screening period of up to 6 weeks, a 12-week induction period, 38-week maintenance period, 52-week long-term extension period, and a 10-week follow-up period.

Study identification

NCT ID
NCT07753850
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Shattuck Labs, Inc.
Industry
Enrollment
232 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 21, 2026 (Estimated)
Primary completion
Jul 2028 (Estimated)
Completion
Jun 2030 (Estimated)
Last update posted
Nov 3, 2026

2026 – 2030

United States locations

U.S. sites
20
U.S. states
11
U.S. cities
20
Facility City State ZIP Site status
Clinical Trial Site Little Rock Arkansas 72205 Not yet recruiting
Clinical Trial Site Oxnard California 93030 Not yet recruiting
Clinical Trial Site Temple City California 91780 Not yet recruiting
Clinical Trial Site West Hills California 91307 Not yet recruiting
Clinical Trial Site Inverness Florida 34452 Not yet recruiting
Clinical Trial Site Kissimmee Florida 34741 Recruiting
Clinical Trial Site Naples Florida 34102 Not yet recruiting
Clinical Trial Site Orlando Florida 32803 Not yet recruiting
Clinical Trial Site Tampa Florida 33607 Not yet recruiting
Clinical Trial Site Kansas City Kansas 66160 Not yet recruiting
Clinical Trial Site Houma Louisiana 70360 Not yet recruiting
Clinical Trial Site Marrero Louisiana 70072 Not yet recruiting
Clinical Trial Site Glen Burnie Maryland 21061 Not yet recruiting
Clinical Trial Site Boston Massachusetts 02115 Not yet recruiting
Clinical Trial Site Liberty Missouri 64068 Not yet recruiting
Clinical Trial Site St Louis Missouri 63110 Not yet recruiting
Clinical Trial Site Maspeth New York 11378 Not yet recruiting
Clinical Trial Site Cincinnati Ohio 45219 Not yet recruiting
Clinical Trial Site Columbus Ohio 43213 Not yet recruiting
Clinical Trial Site Nashville Tennessee 37211 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07753850, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2026 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07753850 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →